LMS Unveils CALM(TM) 3.0 for Obstetrics
March 23 2005 - 8:31AM
PR Newswire (US)
LMS Unveils CALM(TM) 3.0 for Obstetrics A Clinical Information
System with integrated Dynamic Decision Support and Risk Management
Tools MONTREAL, March 23 /PRNewswire-FirstCall/ -- LMS Medical
Systems (AMEX:LMZ; TSX:LMZ), a healthcare technology company and
developer of the CALM(TM) system (Computer Assisted Labor
Management) today announced that it has unveiled its foundation
labor and delivery product suite for large scale healthcare
facilities. The product was showcased at the 2005 Annual Healthcare
Information and Management Systems Society Conference held in
Dallas, Texas. The CALM(TM) product suite provides Physicians,
Nurses and Risk Managers with decision support and risk management
software that have been designed to create a new standard of
patient care and reduce risk in Obstetrics. CALM 3.0 combines a
robust clinical information system that includes advanced
surveillance, archival, and maternal-fetal charting with unique
risk management tools enabling personalized labor evaluation, fetal
monitoring and retrospective assessment. "Obstetrics remains an
extremely complex area of medicine." said Diane Cote, President and
CEO of LMS. "The CALM 3.0 platform is the building block upon which
we will be delivering clinical excellence, interoperability and
efficiencies that benefit both mothers and their babies." CALM 3.0
has been ordered by a number of leading U.S based hospitals.
Initially planned for later this month, facility installation will
commence in July. About LMS: LMS is a leader in the application of
advanced mathematical modeling and neural networks for medical use.
The LMS Computer Assisted Labor Management product suite provides
physicians, nursing staff and risk managers with innovative
obstetrical decision support and risk management tools integrated
into robust clinical information systems designed to improve
outcomes and patient care for mothers and their infants during
labor and delivery. This press release contains forward-looking
statements that involve risks and uncertainties, which may cause
actual results to differ materially from the statements made. For
this purpose, any statements that are contained herein that are not
statements of historical fact may be deemed to be forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Without limiting
the foregoing, the words "believes," "anticipates," "plans,"
"intends," "will," "should," "expects," "projects," and similar
expressions are intended to identify forward-looking statements.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause actual results, future
circumstances, or events to differ materially from those projected
in the forward-looking statements. These risks include, but are not
limited to, those associated with the success of research and
development programs, the adequacy, timing, and results of clinical
trials, the regulatory approval process, competition, securing and
maintaining corporate alliances, market acceptance of the Company's
products, the strength of intellectual property, financing
capability, the potential dilutive effects of any financing,
reliance on subcontractors and key personnel, and other risks
detailed from time-to-time in the Company's public disclosure
documents or other filings with the Canadian and U.S. securities
commissions or other securities regulatory bodies. The
forward-looking statements are made as of the date hereof, and the
Company disclaims any intention and has no obligation or
responsibility, except as required by law, to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise. DATASOURCE: LMS MEDICAL SYSTEMS INC.
CONTACT: Andrea Miller, Communications, LMS Medical Systems Inc.,
(514) 488-3461, ext. 222, Fax: (514) 488-1880, ,
http://www.lmsmedical.com/
Copyright